
An interview with Jessica McDade, B.S.N., RN, OCN, an Extraordinary Healer award finalist.

An interview with Jessica McDade, B.S.N., RN, OCN, an Extraordinary Healer award finalist.

Finding out that some family members have the BRCA gene makes me worried for them regarding the prospect of cancer.

Jessica, a master of the art of nursing, bonds with patients who it can be hard to make connections with.

Cancer's chaos can cause a storm full of unknowns.

For certain patients with HER2-positive gastric cancers, a Keytruda treatment combination has shown promising survival outcomes.

As I approach my 10-year cancerversary, I reflect on the worst and best experiences.

From the death of author Paul Auster and musician Duane Eddy to King Charles’ visit to a cancer hospital, here’s what’s happening in the cancer space this week.

For patients with blood cancers, CAR-T cell therapy has been a “mind-blowing” advancement for treatment in the cancer space.

Adding Calquence to standard-of-care chemoimmunotherapy improved progression-free survival in patients with previously untreated mantle cell lymphoma.

As up to 42% of patients with cancer may be using cannabis, one expert spoke to CURE® to separate cannabis myths from reality.

After recovering from testicular cancer, I feel as though I've earned a second life where I face my fears head-on.

The oncolytic virus, MEM-288 will be studied in combination with Opdivo for patients with non-small cell lung cancer that progressed on standard therapy.

An oncology nurse explained the impacts that organizations like Wonders & Worries can make on children of patients with cancer.

Genetic testing for women with breast cancer is important, as it may help determine the risk of developing secondary primary breast cancer.

Oncology nurse, Meaghan Mooney, B.S.N., RN, OCN, winner of the 2024 Extraordinary Healer® award, celebrates the “small wins” with her patients.

Through so many cancer scares, I'm trying to live in gratitude that my sister's time is not now.

Getting second opinions is highly encouraged for patients recently diagnosed with bladder cancer because “it’s not one size fits all,” experts told CURE®.

This is the poem I wrote to help myself cope with my new diagnosis. It served as a reminder that I was resilient.

Accepting both my beauty and flaws helps me push away the fear cancer brings.

Leaning on a community of oncology nurses, other patients and survivors can help ease the burden of receiving a cancer diagnosis, said Kristen Dahlgren.

A urine test was shown to decrease the need for invasive cystoscopies in patients with non-muscle-invasive bladder cancer.

I need to acknowledge and address the impact stress from multiple myeloma has on my mental and emotional wellbeing.

Alecensa was shown to reduce the risk of disease recurrence or death by 76% versus chemotherapy for patients with ALK-positive non-small cell lung cancer.

It is Meaghan’s unwavering dedication to supporting children and families during a parent’s illness, along with her willingness to take her direct patient care to practices within her professional position and her community service, that allow me to say Meaghan is truly an extraordinary healer deserving of this honor.

I reflected upon my last great trip with my husband and the moment my wait and watch approach ended for my follicular lymphoma.

The Food and Drug Administration approved Tivdak for metastatic cervical cancer that progressed on or after chemotherapy.

The FDA has approved Hercessi for the adjuvant treatment of HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

After nearly 10 years as a breast cancer survivor, I've received so many questions I can't answer about cancer.

This year marks the 18th year that CURE and Oncology Nursing News have hosted the Extraordinary Healer Award for Oncology Nursing, which gives people the opportunity to recognize and honor the oncology nurses who have made a significant impact on their life.

Before patients receive Enhertu for HER2-positive solid tumors, it’s important to know about the potential side effects.